• Arena Pharmaceuticals, Inc. (ARNA) Climbs Ahead of FDA Deadline More...

• European Medicines Agency Validates Gilead Sciences, Inc. (GILD)'s Marketing Application for Elvitegravir for Treatment of HIV Infection More...

• Repros Therapeutics Inc. (RPRX) Receives Official FDA Minutes for Androxal(R) Phase 3 Meeting Held on May 9, 2012 More...

• Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Global Research & Development Center, Inc.'s Announcement on the Acceptance of the EMA Submissions for Two Fixed-Dose Alogliptin Combination Therapies for the Treatment of Type 2 Diabetes More...

• Pfizer Inc. (PFE): Xalkori Improves Lung Cancer Patients' Survival in Phase III Trial More...

• Addex Therapeutics (ADXN.SW) to Present Phase 2a Dipraglurant Data atMovement Disorder Society's International Congress More...

• NewLink Genetics Updates Enrollment Information for Its Pivotal Phase 3 HyperAcute® Pancreas Immunotherapy (algenpantucel-L) Trial More...

• Zalicus Inc. (ZLCS) Successfully Completes Phase 1 Single Ascending Dose Study with Z944 , a Novel, Oral T-Type Calcium Channel Blocker More...

• Palatin Technologies (PTN) Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration More...

• Lonely? Your Health May Suffer, University of California, San Francisco (UCSF) Study More...

• Gum Disease May Lead to Head, Neck Cancers, University at Buffalo Study More...

• Microbiome Analysis Helps Understand Cause of Chronic Sinus Condition,University of California, San Francisco (UCSF) Study More...

• Some May Drink More After Weight-Loss Surgery, University of Pittsburgh Study More...

• Could Psoriasis Increase Odds for Type 2 Diabetes? University of Pennsylvania Study More...

• NeurogesX, Inc. (NGSX) Receives Notice of Two U.S. Patent Allowances Covering NGX-1998 More...

• Femina Pharma Announces Issuance of United States Patent 8,178,123 to Improve Drug Absorption for Cancer And HIV/AIDS Populations More...

• Depomed, Inc. (DEPO) Announces Allowance of Eighth US Patent Covering Gralise® (gabapentin) More...

• Quintiles Transnational Corp. Confirms Layoffs More...

• Merck Serono: Geneva HQs to Close More...

• Xenikos B.V. Secures EUR 5.5 Million in Financing to Support Further Clinical Development of its T-Guard™ Product as an Orphan Drug for Treating Graft-Versus-Host Disease More...

• Nuevolution Raises E11 Million in New Financing Round More...

• KAHR Medical, a Hadasit Bio-Holdings Ltd. (HDST) Portfolio Company, to Raise $2.6 Million More...

• Medgenics, Inc. Raises $9.5 Million in Private Placement More...

• CEL-SCI (CVM) to Raise $5.60 Million in Registered Direct Offering More...

• Piramal Healthcare Limited in Talks to Buy US Contract Drug Maker Cambridge Major Laboratories, Inc. for $200 Million More...

• XTL Biopharmaceuticals Ltd. (XTLB) to Acquire Kitov Pharmaceuticals for Up to $48 Million More...

• AstraZeneca PLC (AZN), Rigel Pharmaceuticals, Inc. (RIGL) Strike Potential $100 Million Asthma Drug Deal More...

• Galaxy Biotech, LLC to Regain Worldwide Rights to HuL2G7, a Clinical Stage Humanized Monoclonal Antibody Against HGF for Treatment of Cancer More...

• Roche (RHHBY), Seaside Therapeutics to Research Autism Treatments More...

• Merck & Co., Inc. (MRK) and Geisinger Health System Form Collaboration More...

• Full Spectrum Genetics, Inc Enters Strategic Collaboration With a Leading Global Pharmaceutical Company More...

• Covance Inc. (CVD) Appoints Dr. Steve Street to Lead Worldwide Safety Assessment and Pharmaceutical Chemistry Services More...

• Acucela Inc. Appoints Business Leader and Entrepreneur Michael Schutzler to the Company's Board of Directors More...

• American Oriental Bioengineering, Inc. (AOBO.OB) Announces Appointment of Audit Committee Chairman More...

• ExecuPharm Announces Global Expansion More...

• Merrimack Pharmaceuticals Inc. Announces the Addition of Cancer Research Pioneer John Mendelsohn, M.D. to Its Board of Directors More...

• Pharma Sales Reps Not Entitled to Overtime: Supreme Court More...

• Pfizer Inc. (PFE) Paid $896 Million in Prempro Accords, Filing Shows More...

• AEterna Zentaris (AEZS) Learns of Class Action Lawsuits Filed and Denies Allegations More...

• Watson Pharmaceuticals, Inc. (WPI) Says US Appeals Court Rules Several Patents on Allergan Inc. (AGN)'s Sanctura XR ae Invalid More...

• Bluestar Silicones Opens New Manufacturing and R&D Center in York, S.C.More...

• Roowin Transfers its Operations to Riom More...

• Bio-Solutions Corp. to Move Corporate Headquarters From Montreal, Canada to San Antonio, Texas More...